VBI Vaccines Announces Presentation of Data from Ongoing Phase 2a Study of VBI-1901 at the 2022 Society for Neuro-Oncology (SNO) Annual Meeting
Stock Information for VBI Vaccines Inc.
Loading
Please wait while we load your information from QuoteMedia.